menu search

VACC / Vaccitech: Aiming For A Cure In Chronic Hepatitis B

Posted: Apr 3 2022, 19:57
Author Name: Seeking Alpha
Views: 102672

VACC News  

Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B

By GlobeNewsWire
June 21, 2023

Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B

OXFORD, United Kingdom, June 21, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disc more_horizontal

Vaccitech to Present at the H.C. Wainwright Global Investment Conference

By GlobeNewsWire
May 20, 2022

Vaccitech to Present at the H.C. Wainwright Global Investment Conference

OXFORD, United Kingdom, May 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disco more_horizontal

Vaccitech: Aiming For A Cure In Chronic Hepatitis B

By Seeking Alpha
April 3, 2022

Vaccitech: Aiming For A Cure In Chronic Hepatitis B

Vaccitech: Aiming For A Cure In Chronic Hepatitis B more_horizontal


Search within

Pages Search Results: